A detailed history of Sbi Securities Co., Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 7 shares of CRL stock, worth $1,317. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 38 81.58%
Holding current value
$1,317
Previous $5.72 Million 81.43%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

SELL
$99.75 - $151.89 $3,092 - $4,708
-31 Reduced 81.58%
7 $1.06 Million
Q1 2025

May 01, 2025

BUY
$150.52 - $190.14 $1,053 - $1,330
7 Added 22.58%
38 $5.72 Million
Q4 2024

Feb 05, 2025

BUY
$178.58 - $220.69 $5,535 - $6,841
31 New
31 $5.72 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.58B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.